author-photo

Chao Huang

University of Kansas

7

Papers

45

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

221 Poor performance status negatively affects survival benefit of immunotherapy in non-small cell lung cancer

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer

2018 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (11)
Biological Agents in Non-small Cell Lung Cancer: A Review of Recent Advances and Clinical Results with a Focus on Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor

2008 Journal of Thoracic Oncology
- Karen Kelly
- Chao Huang
Show All
- Source
- Cite
- Save
Citations (34)
P2-275: Phase ii study of weekly docetaxel (Doc) and gemcitabine (Gem) in relapsed patients (Pts) with advanced, platinum–exposed non–small cell lung cancer (NSCLC)

2007 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase II study of weekly docetaxel and gemcitabine in relapsed patients (pts) with advanced, platinum-exposed non-small cell lung cancer (NSCLC)

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)